{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:39:35Z","timestamp":1761863975760,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.path.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T21:16:37Z","timestamp":1558473397000},"page":"831-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone Pathology for Hematopathologists"],"prefix":"10.1016","volume":"12","author":[{"given":"Deniz","family":"Peker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gene P.","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.path.2019.03.007_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2008.07421.x","article-title":"Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004","volume":"144","author":"Dores","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","article-title":"Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA","volume":"17","author":"Thumallapally","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib4","doi-asserted-by":"crossref","first-page":"e2017052","DOI":"10.4084\/mjhid.2017.052","article-title":"Solitary plasmacytoma","volume":"9","author":"Grammatico","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"4","key":"10.1016\/j.path.2019.03.007_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.14291","article-title":"Progression of a solitary plasmacytoma to multiple myeloma. A\u00a0population-based registry of the northern Netherlands","volume":"175","author":"de Waal","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.path.2019.03.007_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1148\/rg.284075156","article-title":"Diagnostic imaging of solitary tumors of the spine: what to do and say","volume":"28","author":"Rodallec","year":"2008","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-017-0549-1","article-title":"Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel","volume":"11","author":"Caers","year":"2018","journal-title":"J\u00a0Hematol Oncol"},{"issue":"6","key":"10.1016\/j.path.2019.03.007_bib8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2006-04-015784","article-title":"Immunoglobulin free light chains and solitary plasmacytoma of bone","volume":"108","author":"Dingli","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.path.2019.03.007_bib9","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.path.2019.03.007_bib10","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0002-9440(10)62556-4","article-title":"Expression of CD56\/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation","volume":"160","author":"Ely","year":"2002","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1309\/5EL22BH45PHUPM8P","article-title":"Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma","volume":"127","author":"Seegmiller","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2019.03.007_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2407-6-118","article-title":"Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study","volume":"6","author":"Knobel","year":"2006","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.path.2019.03.007_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23201","article-title":"Trends and outcomes of modern staging of solitary plasmacytoma of bone","volume":"87","author":"Warsame","year":"2012","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2019.03.007_bib15","series-title":"WHO classification of tumours of soft tissue and bone","first-page":"275","article-title":"Osteogenic tumours","year":"2013"},{"issue":"8","key":"10.1016\/j.path.2019.03.007_bib16","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.humpath.2014.04.010","article-title":"Changing prognostic factors in osteosarcoma: analysis of 381 cases from two institutions","volume":"45","author":"Xing","year":"2014","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.12138","article-title":"SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours","volume":"63","author":"Conner","year":"2013","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.path.2019.03.007_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1309\/AJCP6V4YPFBOCYXG","article-title":"CD138 (syndecan-1) expression in bone-forming tumors","volume":"137","author":"Nunez","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.path.2019.03.007_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2106\/JBJS.N.01350","article-title":"Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009","volume":"97","author":"Kremers","year":"2015","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.idc.2017.01.010","article-title":"Osteomyelitis","volume":"31","author":"Schmitt","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"Suppl 1","key":"10.1016\/j.path.2019.03.007_bib21","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1007\/s00247-011-2001-y","article-title":"Infection: musculoskeletal","volume":"41","author":"Jaramillo","year":"2011","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.21037\/qims.2016.04.01","article-title":"The imaging of osteomyelitis","volume":"6","author":"Lee","year":"2016","journal-title":"Quant Imaging Med Surg"},{"year":"2018","series-title":"Osteomyelitis","author":"Momodu","key":"10.1016\/j.path.2019.03.007_bib23"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOP.0b013e3282f45ba4","article-title":"Langerhans cell histiocytosis: update for the pediatrician","volume":"20","author":"Weitzman","year":"2008","journal-title":"Curr Opin Pediatr"},{"issue":"9365","key":"10.1016\/j.path.2019.03.007_bib25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(03)12990-X","article-title":"Langerhans' cell histiocytosis","volume":"361","author":"Leonidas","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.21498","article-title":"Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004","volume":"51","author":"Guyot-Goubin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radcr.2017.11.020","article-title":"Langerhans cell histiocytosis of bone in an adult: a case report","volume":"13","author":"Christopher","year":"2018","journal-title":"Radiol Case Rep"},{"issue":"11","key":"10.1016\/j.path.2019.03.007_bib29","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/theoncologist.2013-0341","article-title":"New insights into the molecular pathogenesis of langerhans cell histiocytosis","volume":"19","author":"Rizzo","year":"2014","journal-title":"Oncologist"},{"year":"2008","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.path.2019.03.007_bib31"},{"key":"10.1016\/j.path.2019.03.007_bib32","first-page":"126","article-title":"Mastocytosis presenting as a skeletal disorder","volume":"16","author":"Delsignore","year":"1996","journal-title":"Iowa Orthop J"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","article-title":"Bone involvement and osteoporosis in mastocytosis","volume":"34","author":"Rossini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.path.2019.03.007_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.iac.2018.04.013","article-title":"Bone disease in mastocytosis","volume":"38","author":"Orsolini","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/leu.2015.176","article-title":"Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression","volume":"30","author":"Mayado","year":"2016","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.path.2019.03.007_bib36","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.18632\/oncotarget.4213","article-title":"Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder","volume":"6","author":"Chatterjee","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.path.2019.03.007_bib37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ajh.24426","article-title":"Next-generation sequencing in systemic mastocytosis: derivation of a mutation-augmented clinical prognostic model for survival","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.path.2019.03.007_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","article-title":"Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics","volume":"137","author":"Haenisch","year":"2012","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib39","first-page":"19","article-title":"Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity","volume":"7","author":"Foucar","year":"1990","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"10.1016\/j.path.2019.03.007_bib40","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0b013e3181ea50b2","article-title":"Primary Rosai-Dorfman disease of bone: a clinicopathologic study of 15 cases","volume":"34","author":"Demicco","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.03.007_bib41","first-page":"175","article-title":"Musculoskeletal involvement in sarcoidosis","volume":"40","author":"Nessrine","year":"2014","journal-title":"J\u00a0Bras Pneumol"},{"issue":"5","key":"10.1016\/j.path.2019.03.007_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/PAP.0000000000000036","article-title":"Round cell tumors of bone: an update on recent molecular genetic advances","volume":"21","author":"Wei","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2019.03.007_bib43","series-title":"WHO classification of tumours of soft tissue and bone","first-page":"305","article-title":"Ewing sarcoma","author":"de Alava","year":"2013"},{"key":"10.1016\/j.path.2019.03.007_bib44","series-title":"Atlas of bone pathology","first-page":"237","article-title":"Small, round cell lesions","year":"2013"},{"key":"10.1016\/j.path.2019.03.007_bib45","series-title":"WHO classification of tumours of soft tissue and bone","first-page":"271","article-title":"Mesenchymal chondrosarcoma","author":"Nakashima","year":"2013"},{"key":"10.1016\/j.path.2019.03.007_bib46","series-title":"Atlas of bone pathology","first-page":"101","article-title":"Cartilage-forming tumors","year":"2013"},{"issue":"4","key":"10.1016\/j.path.2019.03.007_bib47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/his.12985","article-title":"CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases","volume":"69","author":"Gambarotti","year":"2016","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.path.2019.03.007_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.path.2019.03.007_bib49","first-page":"321","article-title":"Bone metastases: an overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol Rev"},{"issue":"18","key":"10.1016\/j.path.2019.03.007_bib50","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"issue":"23","key":"10.1016\/j.path.2019.03.007_bib51","first-page":"7710","article-title":"Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer","volume":"50","author":"Southby","year":"1990","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"10.1016\/j.path.2019.03.007_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1015599831232","article-title":"Prostate carcinoma skeletal metastases: cross-talk between tumor and bone","volume":"20","author":"Keller","year":"2001","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"10.1016\/j.path.2019.03.007_bib53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1471-4914(02)02340-7","article-title":"Transcription factors in bone: developmental and pathological aspects","volume":"8","author":"Yang","year":"2002","journal-title":"Trends Mol Med"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:40:23Z","timestamp":1761748823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1875918119300248"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.03.007","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Pathology for Hematopathologists","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}